I entirely agree with Dr McBride: patient choice in their treatment is key – and that demands both access to the different treatment options, as well as accurate, informed discussion about the pros and cons of every treatment, from outcomes to process. All of the treatments approved by NICE and available in the UK have a role to play in successfully treating prostate cancer.
But we should not over emphasise one type of treatment – such as radical prostatectomy - without considering the full breadth of options.
